50 results
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
and healthy environment for our directors, members of management and stockholders who wish to attend the Annual Meeting. You will be able to attend … business environment, as well as the commitment required to serve as our Chairman, particularly as the board of directors’ oversight responsibilities
8-K
EX-10.1
61cyujlg3cho mrnj06
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
la76vdbg
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-10.1
1e4kbjd lclnia6bnms
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.2
e622elqt
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
EX-99.1
6fchabv sutjg
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
DEFA14A
zhzhc0zzb49w
7 Apr 22
Additional proxy soliciting materials
4:00pm
8-K
EX-10.1
6sum37cejrl9pd6wkaq
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
424B5
tijevy oyom93vzia6v
16 Mar 22
Prospectus supplement for primary offering
8:00am